Cargando…
AID/APOBEC deaminases and cancer
Mutations are the basis for evolution and the development of genetic diseases. Especially in cancer, somatic mutations in oncogenes and tumor suppressor genes alongside the occurrence of passenger mutations have been observed by recent deep-sequencing approaches. While mutations have long been consi...
Autores principales: | Rebhandl, Stefan, Huemer, Michael, Greil, Richard, Geisberger, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468319/ https://www.ncbi.nlm.nih.gov/pubmed/26097867 |
Ejemplares similares
-
APOBEC3 signature mutations in chronic lymphocytic leukemia
por: Rebhandl, S, et al.
Publicado: (2014) -
AIDing cancer treatment: Reducing AID activity via HSP90 inhibition
por: Rebhandl, Stefan, et al.
Publicado: (2015) -
Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia
por: Rebhandl, Stefan, et al.
Publicado: (2014) -
AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells
por: Huemer, Michael, et al.
Publicado: (2014) -
Molecular targeting of mutagenic AID and APOBEC deaminases
por: Nabel, Christopher S, et al.
Publicado: (2014)